An innovative hub of pharmaceutical manufacturers
Companies from the pharmaceutical industry benefit from an excellent research and clinical landscape in Berlin as a pharmaceutical location.
The sustainable success of the pharmaceuticals industry in Berlin-Brandenburg is based on a history of innovative products going back to the 19th century. Global players such as Bayer, Berlin-Chemie (Menarini), Pfizer, Sanofi, and Takeda as well as about 30 pharmaceutical SMEs are based in Berlin-Brandenburg and employ around 11,000 people.
The industry benefits from
- an excellent scientific and clinical environment
- the biotech expertise in the region
- proximity to the decision-makers for the German healthcare system
- the central geographical location of the German capital region with good access to Western, Central, and Eastern European markets
- the close connection between research, development, and clinical practice
- well established translational research
- excellent infrastructure for technology transfer
- numerous options for clinical trials
With a large and diverse patient population and 145 hospitals, the Berlin-Brandenburg region makes all types of clinical research projects possible.
#1 site for clinical trials in Germany
Berlin leads the list of cities in Germany with a high number of students by a wide margin. This is the result of a survey by the industry association vfa based on the clinicaltrials.gov study registry (as of: 2022).
Pharmaceutical companies in the capital region
There are currently approx. 35 pharmaceuticals companies in the capital region.